| John A Lieberman, DO | |
|
4401 N Campus Ridge Dr, Suite B2200, Midland, MI 48640-6112 | |
| (989) 837-9400 | |
| Not Available |
| Full Name | John A Lieberman |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 24 Years |
| Location | 4401 N Campus Ridge Dr, Midland, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912995762 | NPI | - | NPPES |
| 1912995762 | Medicaid | MI | |
| 4615318 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 5315016828 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center-midland | Midland, MI | Hospital |
| Midmichigan Medical Center-gladwin | Gladwin, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mymichigan Medical Center Midland | 2264323633 | 338 |
News Archive
Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies.
According to a new study by the National Institutes of Health, people with moderate to severe joint discomfort found that a combination of glucosamine and chondroitin resulted in significant pain and function improvement.
Every eight adult Swede suffers from migraine. Using a new method, researchers at Göteborg have managed for the first time ever to provide a detailed picture of an untreated attack. This will be of great significance for the development of new forms of treatment.
GVK Biosciences (GVK BIO), Asia's leading integrated research services provider and Quantitative Solutions (QS), a modeling and simulation (M&S) consultancy to the pharmaceutical and biotech industry, announced a strategic partnership to develop and market clinical trial outcome databases.
Gilead Sciences, Inc. today announced data from a Phase IIa study showing that its investigational compounds GS 9190 and GS 9256, used in conjunction with current standard of care therapies, produced substantial suppression of the hepatitis C virus (HCV) within 28 days of treatment.
› Verified 9 days ago
| Entity Name | Mymichigan Medical Center Midland |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205889490 PECOS PAC ID: 2264323633 Enrollment ID: O20040324000137 |
News Archive
Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies.
According to a new study by the National Institutes of Health, people with moderate to severe joint discomfort found that a combination of glucosamine and chondroitin resulted in significant pain and function improvement.
Every eight adult Swede suffers from migraine. Using a new method, researchers at Göteborg have managed for the first time ever to provide a detailed picture of an untreated attack. This will be of great significance for the development of new forms of treatment.
GVK Biosciences (GVK BIO), Asia's leading integrated research services provider and Quantitative Solutions (QS), a modeling and simulation (M&S) consultancy to the pharmaceutical and biotech industry, announced a strategic partnership to develop and market clinical trial outcome databases.
Gilead Sciences, Inc. today announced data from a Phase IIa study showing that its investigational compounds GS 9190 and GS 9256, used in conjunction with current standard of care therapies, produced substantial suppression of the hepatitis C virus (HCV) within 28 days of treatment.
› Verified 9 days ago
| Entity Name | Mymichigan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689623506 PECOS PAC ID: 4981501939 Enrollment ID: O20060727000013 |
News Archive
Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies.
According to a new study by the National Institutes of Health, people with moderate to severe joint discomfort found that a combination of glucosamine and chondroitin resulted in significant pain and function improvement.
Every eight adult Swede suffers from migraine. Using a new method, researchers at Göteborg have managed for the first time ever to provide a detailed picture of an untreated attack. This will be of great significance for the development of new forms of treatment.
GVK Biosciences (GVK BIO), Asia's leading integrated research services provider and Quantitative Solutions (QS), a modeling and simulation (M&S) consultancy to the pharmaceutical and biotech industry, announced a strategic partnership to develop and market clinical trial outcome databases.
Gilead Sciences, Inc. today announced data from a Phase IIa study showing that its investigational compounds GS 9190 and GS 9256, used in conjunction with current standard of care therapies, produced substantial suppression of the hepatitis C virus (HCV) within 28 days of treatment.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John A Lieberman, DO 4401 N Campus Ridge Dr, Suite B2200, Midland, MI 48640-6112 Ph: (989) 837-9400 | John A Lieberman, DO 4401 N Campus Ridge Dr, Suite B2200, Midland, MI 48640-6112 Ph: (989) 837-9400 |
News Archive
Bristol-Myers Squibb Company and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies.
According to a new study by the National Institutes of Health, people with moderate to severe joint discomfort found that a combination of glucosamine and chondroitin resulted in significant pain and function improvement.
Every eight adult Swede suffers from migraine. Using a new method, researchers at Göteborg have managed for the first time ever to provide a detailed picture of an untreated attack. This will be of great significance for the development of new forms of treatment.
GVK Biosciences (GVK BIO), Asia's leading integrated research services provider and Quantitative Solutions (QS), a modeling and simulation (M&S) consultancy to the pharmaceutical and biotech industry, announced a strategic partnership to develop and market clinical trial outcome databases.
Gilead Sciences, Inc. today announced data from a Phase IIa study showing that its investigational compounds GS 9190 and GS 9256, used in conjunction with current standard of care therapies, produced substantial suppression of the hepatitis C virus (HCV) within 28 days of treatment.
› Verified 9 days ago
Mrs. Kelly Marie Hamilton, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4401 Campus Ridge Dr Ste Ll110, Midland, MI 48640 Phone: 989-837-9400 Fax: 989-837-9410 | |
Paula Reif Headbloom, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3306 Thornbrook Ct, Midland, MI 48640 Phone: 989-859-1233 Fax: 989-631-4960 | |
Mr. Mark Edward English Jr., MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4401 Campus Ridge Dr Ste Ll110, Midland, MI 48640 Phone: 989-837-9400 | |
Cheryl Dwyer, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4320 Campus Ridge Drive, Midland, MI 48640 Phone: 989-839-3170 Fax: 989-839-1840 | |
Dr. Elvira Mikhailovna O'brien, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4401 Campus Ridge Dr Ste Ll110, Midland, MI 48640 Phone: 989-837-9400 Fax: 989-837-9410 | |
Dr. David Allen Junge, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4009 Orchard Drive, Suite #3025, Midland, MI 48640 Phone: 989-631-7913 Fax: 989-631-5798 | |
Dr. Sandeep Sambrani Rao, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4401 N Campus Ridge Dr, #b2200, Midland, MI 48640 Phone: 989-837-9400 |